Suchergebnisse - "Langer, Jakob"

PubPharm (20)

1

Understanding the Global Burden of Influenza in Adults Aged 18–64 years: A Systematic Literature Review from 2012 to 2022

enthalten in: Advances in therapy | 2023

von Maleki, F. | Welch, V. | Lopez, S. | +7

2

A Japanese Study Assessing Glycemic Control with Use of IDegAsp Co-formulation in Patients with Type 2 Diabetes in Clinical Practice: The JAGUAR Study

enthalten in: Advances in therapy | 2021

von Kaneko, S. | da Rocha Fernandes, J. | Yamamoto, Y. | +2

3

Effect of Orally Administered Semaglutide Versus Dulaglutide on Diabetes-Related Quality of Life in Japanese Patients with Type 2 Diabetes: The PIONEER 10 Randomized, Active-Controlled Trial

enthalten in: Diabetes therapy | 2021

von Ishii, H. | Hansen, B. | Langer, J. | +1

4

Preference for Oral and Injectable GLP-1 RA Therapy Profiles in Japanese Patients with Type 2 Diabetes: A Discrete Choice Experiment

enthalten in: Advances in therapy | 2020

von Igarashi, A. | Bekker Hansen, B. | Langer, J. | +4

5

Quality of Life and Utility Values for Cost-Effectiveness Modeling in Japanese Patients with Type 2 Diabetes

enthalten in: Diabetes therapy | 2020

von Ishii, H. | Takamura, H. | Nishioka, Y. | +4

6

Lower Drug Cost of Successfully Treating Patients with Type 2 Diabetes to Targets with Once-Weekly Semaglutide versus Once-weekly Dulaglutide in Japan: A Short-Term Cost-Effectiveness Analysis

enthalten in: Advances in therapy | 2020

von Igarashi, A. | Hunt, B. | Wilkinson, L. | +2

7

Response to “Letter to the Editor Regarding: Patient Preferences for Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment”

enthalten in: Diabetes therapy | 2020

von Brooks, A. | Langer, J. | Tervonen, T. | +3

8

Short-Term Cost-Effectiveness of Switching to Insulin Degludec in Japanese Patients with Type 2 Diabetes Receiving Basal–Bolus Therapy

enthalten in: Diabetes therapy | 2019

von Langer, J. | Wolden, M. | Shimoda, S. | +2

9

Patient Preferences for GLP-1 Receptor Agonist Treatment of Type 2 Diabetes Mellitus in Japan: A Discrete Choice Experiment

enthalten in: Diabetes therapy | 2019

von Brooks, A. | Langer, J. | Tervonen, T. | +3

10

A Network Meta-Analysis Comparing Semaglutide Once-Weekly with Other GLP-1 Receptor Agonists in Japanese Patients with Type 2 Diabetes

enthalten in: Diabetes therapy | 2018

von Webb, N. | Orme, M. | Witkowski, M. | +2